Abstract
Here, we show that FoxO3A transcription factor is upregulated upon calpain small-1 (CAPNS1) depletion both in mouse embryonic fibroblasts (MEFs) and in the human mammary carcinoma cell line MCF-7. On starvation, CAPNS1 depletion is associated with a higher rate of FoxO3A dephosphorylation and translocation to the nucleus and to a sharper increase in the levels of p27Kip1 and Bim, the products of two FoxO target genes. Notably, FoxO3A depletion in CAPNS1−/− MEFs reduces both the induction of Bim and apoptosis. Both okadaic acid treatment and silencing of the protein phosphatase 2A (PP2A) catalytic subunit can partially reduce starvation-induced FoxO3A activation and apoptosis in CAPNS1−/− fibroblasts. PP2A associates more tightly with Akt in CAPNS1 knockout cells, indicating that PP2A is involved in calpain-mediated FoxO regulation. Finally, we show that PP2A regulatory subunits B56 alpha and gamma are in vitro substrates of calpain, and calpain regulates B56 alpha stability in vivo, suggesting a direct role of calpain in the regulation of PP2A function. In conclusion, for the first time we report that CAPNS1 interferes with PP2A-Akt interaction consequently affecting FoxO3A-dependent cell death. Calpain inhibition might therefore be exploited as a tool to induce apoptosis in tumors sensitive to FoxO activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altomare DA, Testa JR . (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455–7464.
Andrabi S, Gjoerup OV, Kean JA, Roberts TM, Schaffhausen B . (2007). Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc Natl Acad Sci USA 104: 19011–19016.
Arthur JS, Elce JS, Hegadorn C, Williams K, Greer PA . (2000). Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 20: 4474–4481.
Barreyro FJ, Kobayashi S, Bronk SF, Werneburg NW, Malhi H, Gores GJ . (2007). Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J Biol Chem 282: 27141–27154.
Biggs III WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC . (1999). Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421–7426.
Brummelkamp TR, Bernards R, Agami R . (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550–553.
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857–868.
Carragher NO, Fonseca BD, Frame MC . (2004). Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 6: 53–73.
Darnell GA, Schroder WA, Antalis TM, Lambley E, Major L, Gardner J et al. (2007). Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein. J Biol Chem 282: 37492–37500.
Demarchi F, Bertoli C, Copetti T, Eskelinen EL, Schneider C . (2007). Calpain as a novel regulator of autophagosome formation. Autophagy 3: 235–237.
Demarchi F, Bertoli C, Copetti T, Tanida I, Brancolini C, Eskelinen EL et al. (2006). Calpain is required for macroautophagy in mammalian cells. J Cell Biol 175: 595–605.
Demarchi F, Bertoli C, Greer PA, Schneider C . (2005). Ceramide triggers an NF-kappaB-dependent survival pathway through calpain. Cell Death Differ 12: 512–522.
Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L et al. (2002). FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 156: 531–542.
Dourdin N, Bhatt AK, Dutt P, Greer PA, Arthur JS, Elce JS et al. (2001). Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 276: 48382–48388.
Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS et al. (2005). Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24: 2317–2329.
Gao T, Furnari F, Newton AC . (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13–24.
Goll DE, Thompson VF, Li H, Wei W, Cong J . (2003). The calpain system. Physiol Rev 83: 731–801.
Greer EL, Brunet A . (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410–7425.
Guan N, Korukonda R, Hurh E, Schmittgen TD, Donkor IO, Dalton JT . (2006). Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. Int J Oncol 29: 655–663.
Harriman JF, Liu XL, Aleo MD, Machaca K, Schnellmann RG . (2002). Endoplasmic reticulum Ca(2+) signaling and calpains mediate renal cell death. Cell Death Differ 9: 734–741.
Janssens V, Goris J . (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353: 417–439.
Kops GJ, Burgering BM . (1999). Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med 77: 656–665.
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947.
Libertini SJ, Robinson BS, Dhillon NK, Glick D, George M, Dandekar S et al. (2005). Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res 65: 10700–10708.
Manning BD, Cantley LC . (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261–1274.
Millward TA, Zolnierowicz S, Hemmings BA . (1999). Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24: 186–191.
Mumby M . (2007). PP2A: unveiling a reluctant tumor suppressor. Cell 130: 21–24.
Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR . (2000). Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20: 8969–8982.
Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z et al. (2007). FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309–323.
Reagan-Shaw S, Ahmad N . (2006). RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells. Cancer Res 66: 1062–1069.
Resjo S, Goransson O, Harndahl L, Zolnierowicz S, Manganiello V, Degerman E . (2002). Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal 14: 231–238.
Rocher G, Letourneux C, Lenormand P, Porteu F . (2007). Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity. J Biol Chem 282: 5468–5477.
Sablina AA, Chen W, Arroyo JD, Corral L, Hector M, Bulmer SE et al. (2007). The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 129: 969–982.
Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A et al. (2004). Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399–412.
Sato S, Fujita N, Tsuruo T . (2000). Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 97: 10832–10837.
Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM . (1999). Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283: 2089–2091.
Sunters A, Fernandez de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA et al. (2003). FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278: 49795–49805.
Tan Y, Wu C, De Veyra T, Greer PA . (2006). Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 281: 17689–17698.
Tang ED, Nunez G, Barr FG, Guan KL . (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274: 16741–16746.
Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP . (2006). Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523–527.
Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A et al. (2003). Pten dose dictates cancer progression in the prostate. PLoS Biol 1: E59.
van der Horst A, Burgering BM . (2007). Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440–450.
Van Kanegan MJ, Adams DG, Wadzinski BE, Strack S . (2005). Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J Biol Chem 280: 36029–36036.
Xu L, Deng X . (2006). Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J Biol Chem 281: 35567–35575.
Yan L, Lavin VA, Moser LR, Cui Q, Kanies C, Yang E . (2008). PP2A regulates the pro-apoptotic activity of FOXO1. J Biol Chem 283: 7411–7420.
Yin KJ, Hsu CY, Hu XY, Chen H, Chen SW, Xu J et al. (2006). Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death. J Neurosci 26: 2290–2299.
You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M et al. (2006). FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med 203: 1657–1663.
Zatz M, Starling A . (2005). Calpains and disease. N Engl J Med 352: 2413–2423.
Zhang X, Gan L, Pan H, Guo S, He X, Olson ST et al. (2002). Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J Biol Chem 277: 45276–45284.
Acknowledgements
We acknowledge Silvano Piazza for help in statistics. CB was a recipient of an FIRC (Fondazione italiana per la ricerca sul cancro) fellowship. This study was supported by PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) 2006-prot. 2006053543_003, and TRANSFOG (Translational and Functinal Onco-Genomics) EU Contract 503438, AIRC (Associazione italiana per la ricerca sul cancro) Grant proposal 2007 Cod. 4752, and Progetto FAR CT cod. MIUR prog. 10036.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Bertoli, C., Copetti, T., Lam, EF. et al. Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Oncogene 28, 721–733 (2009). https://doi.org/10.1038/onc.2008.425
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.425
Keywords
This article is cited by
-
The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα–SOD2 pathway
Cell Death & Differentiation (2020)
-
Calpain7 impairs embryo implantation by downregulating β3-integrin expression via degradation of HOXA10
Cell Death & Disease (2018)
-
Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition
Naunyn-Schmiedeberg's Archives of Pharmacology (2018)
-
Pericyte-expressed Tie2 controls angiogenesis and vessel maturation
Nature Communications (2017)
-
Calpain-1 deletion impairs mGluR-dependent LTD and fear memory extinction
Scientific Reports (2017)